Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2014
  • Online publication date: October 2014

Section 5 - Research: Mediators and Moderators

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

A Concise Guide to Understanding Suicide
  • Online ISBN: 9781139519502
  • Book DOI: https://doi.org/10.1017/CBO9781139519502
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Akula, N., Baranova, A., Seto, D., et al. (2011). A network-based approach to prioritize results from genome-wide association studies. PLoS One, 6(9), e24220.
Altshuler, D., & Daly, M. (2007). Guilt beyond a reasonable doubt. Nature Genetics, 39(7), 813–815.
Baca-Garcia, E., Perez-Rodriguez, M. M., Oquendo, M. A., et al. (2011). Estimating risk for suicide attempt: are we asking the right questions? Passive suicidal ideation as a marker for suicidal behavior. Journal of Affective Disorders, 134(1–3), 327–332.
Ben-Efraim, Y. J., Wasserman, D., Wasserman, J., et al. (2011). Gene-environment interactions between CRHR1 variants and physical assault in suicide attempts. Genes, Brain and Behavior, 10(6), 663–672.
Ben-Efraim, Y. J., Wasserman, D., Wasserman, J., & Sokolowski, M. (2012). Family-based study of HTR2A in suicide attempts: observed gene, gene × environment and parent-of-origin associations. Molecular Psychiatry, 18(7), 758–766.
Ben-Efraim, Y. J., Wasserman, D., Wasserman, J., et al. (2013). Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology, 38(8), 1504–1511.
Bhat, S., Dao, D. T., Terrillion, C. E., et al. (2012). CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Progress in Neurobiology, 99(1), 1–14.
Binder, E. B., (2012). The genetic basis of mood and anxiety disorders – changing paradigms. Biology of Mood and Anxiety Disorders, 2(1), 17.
Bouaziz, M., Ambroise, C., & Guedj, M. (2011). Accounting for population stratification in practice: a comparison of the main strategies dedicated to genome-wide association studies. PLoS One, 6(12), e28845.
Butali, A., Suzuki, D., Cooper, M. E., et al. (2013). Replication of genome wide association identified candidate genes confirm the role of common and rare variants in PAX7 and VAX1 in the etiology of nonsyndromic CL(P). American Journal of Medical Genetics A, 161A(5), 965–972.
Califano, A., Butte, A. J., Friend, S., et al. (2012). Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nature Genetics, 44(8), 841–847.
Cardon, L. R., & Palmer, L. J. (2003). Population stratification and spurious allelic association. Lancet, 361(9357), 598–604.
Currier, D., & Mann, J. J. (2008). Stress, genes and the biology of suicidal behavior. Psychiatric Clinics of North America, 31(2), 247–269.
den Hoed, M., Eijgelsheim, M., Esko, T., et al. (2013). Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nature Genetics, 45(6), 621–631.
Deo, A. J., Huang, Y. Y., Hodgkinson, C. A., et al. (2013). A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction. Psychiatric Genetics, 23(2), 47–55.
Diogo, D., Kurreeman, F., Stahl, E. A., et al. (2013). Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. American Journal of Human Genetics, 92(1), 15–27.
Eichler, E. E., Flint, J., Gibson, G., et al. (2010). Missing heritability and strategies for finding the underlying causes of complex disease. Nature Reviews Genetics, 11(6), 446–450.
Ernst, C., Mechawar, N., & Turecki, G. (2009). Suicide neurobiology. Progress in Neurobiology, 89(4), 315–333.
Galfalvy, H., Zalsman, G., Huang, Y. Y., et al. (2011). A pilot genome wide association and gene expression array study of suicide with and without major depression. World Journal of Biological Psychiatry, 14(8), 574–582.
Goldstein, D. B., Ahmadi, K. R., Weale, M. E., et al. (2003). Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends in Genetics, 19(11), 615–622.
Hamshere, M. L., Walters, J. T., Smith, R., et al. (2013). Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Molecular Psychiatry,18(6), 708–712.
Hannum, G., Srivas, R., Guenole, A., et al. (2009). Genome-wide association data reveal a global map of genetic interactions among protein complexes. PLoS Genetics, 5(12), e1000782.
Holmans, P. (2010). Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits. Advances in Genetics, 72, 141–179.
Ikegawa, S. (2012). A short history of the genome-wide association study: where we were and where we are going. Genomics Inform, 10(4), 220–225.
Jia, P., Kao, C. F., Kuo, P. H., et al. (2011a). A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Systems Biology, 5 (Suppl 3), S12.
Jia, P., Zheng, S., Long, J., et al. (2011b). dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics, 27(1), 95–102.
Jia, P., Wang, L., Fanous, A. H., et al. (2012). Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Computational Biology, 8(7), e1002587.
Kendler, K. S. (2010). Genetic and environmental pathways to suicidal behavior: reflections of a genetic epidemiologist. European Psychiatry, 25(5), 300–303.
Kofink, D., Boks, M. P., Timmers, H. T., et al. (2013). Epigenetic dynamics in psychiatric disorders: Environmental programming of neurodevelopmental processes. Neuroscience and Biobehavioral Reviews, 37(5), 831–845.
Laje, G., Allen, A. S., Akula, N., et al. (2009). Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenetic Genomics, 19(9), 666–674.
Lambert, C. G., & Black, L. J. (2012). Learning from our GWAS mistakes: from experimental design to scientific method. Biostatistics, 13(2), 195–203.
Lee, I., Blom, U. M., Wang, P. I., et al. (2011). Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Research, 21(7), 1109–1121.
Lehne, B., Lewis, C. M., & Schlitt, T. (2011). From SNPs to genes: disease association at the gene level. PLoS One, 6(6), e20133.
Lehner, B. (2013). Genotype to phenotype: lessons from model organisms for human genetics. Nature Reviews Genetics, 14(3), 168–178.
Leigh, H. (2009). A proposal for a new multiaxial model of psychiatric diagnosis. A continuum-based patient model derived from evolutionary developmental gene-environment interaction. Psychopathology, 42(1), 1–10.
Li, M. X., Yeung, J. M., Cherny, S. S., et al. (2012a). Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets. Human Genetics, 131(5), 747–756.
Li, M. X., Kwan, J. S., & Sham, P. C. (2012b). HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis. American Journal of Human Genetics, 91(3), 478–488.
Liu, Y. J., Zhang, L., Pei, Y., et al. (2013). On genome-wide association studies and their meta-analyses: lessons learned from osteoporosis studies. Journal of Clinical Endocrinology and Metabolism, 98(7), E1278–1282
Mann, J. J., Arango, V. A., Avenevoli, S., et al. (2009). Candidate endophenotypes for genetic studies of suicidal behavior. Biological Psychiatry, 65(7), 556–563.
Marchini, J., & Howie, B. (2010). Genotype imputation for genome-wide association studies. Nature Reviews Genetics, 11(7), 499–511.
McKinney, B. A., & Pajewski, N. M. (2011). Six degrees of epistasis: statistical network models for GWAS. Frontiers in Genetics, 2, 109.
Menke, A., Domschke, K., Czamara, D., et al. (2012). Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology, 37(3), 797–807.
Meyer-Lindenberg, A., & Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 7(10), 818–827.
Moore, S., Kelleher, E., & Corvin, A. (2011). The shock of the new: progress in schizophrenia genomics. Current Genomics, 12(7), 516–524.
Need, A. C., & Goldstein, D. B. (2010). Whole genome association studies in complex diseases: where do we stand?Dialogues in Clinical Neuroscience, 12(1), 37–46.
Nicolae, D. L., Gamazon, E., Zhang, W., et al. (2010). Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genetics, 6(4), e1000888.
Ober, C., Loisel, D. A., & Gilad, Y. (2008). Sex-specific genetic architecture of human disease. Nature Reviews Genetics, 9(12), 911–922.
Perlis, R. H., Huang, J., Purcell, S., et al. (2010). Genome-wide association study of suicide attempts in mood disorder patients. American Journal of Psychiatry, 167(12), 1499–1507.
Perroud, N., Uher, R., Ng, M. Y., et al. (2012). Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics Journal, 12(1), 68–77.
Purcell, S. M., Wray, N. R., Stone, J. L., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752.
Rietveld, C. A., Medland, S. E., Derringer, J., et al. (2013). GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science, 340(6139), 1467–1471.
Rowe, S. J., & Tenesa, A. (2012). Human complex trait genetics: lifting the lid of the genomics toolbox – from pathways to prediction. Current Genomics, 13(3), 213–224.
Rujescu, D., & Giegling, I. (2010). The genetics of neurosystems in mental ill-health and suicidality: beyond serotonin. European Journal of Psychiatry, 25(5), 272–274.
Schork, N. J., Murray, S. S., Frazer, K. A., et al. (2009). Common vs. rare allele hypotheses for complex diseases. Current Opinion in Genetic Development, 19(3), 212–219.
Schosser, A., Butler, A. W., Ising, M., et al. (2011). Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS One, 6(7), e20690.
Schulze, T. G., Akula, N., Breuer, R., et al. (2012). Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World Journal of Biological Psychiatry [Epub ahead of print].
Scriver, C. R. (2007). The PAH gene, phenylketonuria, and a paradigm shift. Human Mutatation, 28(9), 831–845.
Sebastiani, P., Solovieff, N., Puca, A., et al. (2010). Genetic signatures of exceptional longevity in humans. Science [Epub 2010 Jul 1].
Sebastiani, P., Solovieff, N., Puca, A., et al. (2011). Retraction. Science, 333(6041), 404.
Smoller, J. W., Craddock, N., Kendler, K., et al. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet, 381(9875), 1371–1379.
So, H. C., Li, M., & Sham, P. C. (2011). Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genetic Epidemiology, 35(6), 447–456.
Sokolowski, M., Wasserman, J., & Wasserman, D. (2010). Association of polymorphisms in the SLIT2 axonal guidance gene with anger in suicide attempters. Molecular Psychiatry, 15(1), 10–11.
Sokolowski, M., Ben-Efraim, Y. J., Wasserman, J., et al. (2012). Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Molecular Psychiatry, 18(9):985–992.
Sun, J., Wan, C., Jia, P., et al. (2011). Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophrenia Research, 125(2–3), 201–208.
Terwilliger, J. D., & Goring, H. H. (2009). Update to Terwilliger and Goring’s “Gene mapping in the 20th and 21st centuries” (2000): gene mapping when rare variants are common and common variants are rare. Human Biology, 81(5–6), 729–733.
Teslovich, T. M., Musunuru, K., Smith, A. V., et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466(7307), 707–713.
Thornton, K. R., Foran, A. J., & Long, A. D. (2013). Properties and modeling of GWAS when complex disease risk is due to non-complementing, deleterious mutations in genes of large effect. PLoS Genetics, 9(2), e1003258.
Vinkhuyzen, A. A., Pedersen, N. L., Yang, J., et al. (2012). Common SNPs explain some of the variation in the personality dimensions of neuroticism and extraversion. Translational Psychiatry, 2, e102.
Visscher, P. M., Brown, M. A., McCarthy, M. I., et al. (2012). Five years of GWAS discovery. American Journal of Human Genetics, 90(1), 7–24.
Voracek, M., & Loibl, L. M. (2007). Genetics of suicide: a systematic review of twin studies. Wiener klinische Wochenschrift, 119(15–16), 463–475.
Wasserman, D., Geijer, T., Rozanov, V., et al. (2005). Suicide attempt and basic mechanisms in neural conduction: relationships to the SCN8A and VAMP4 genes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 133B(1), 116–119.
Wasserman, D., Geijer, T., Sokolowski, M., et al. (2007). Genetic variation in the hypothalamic-pituitary-adrenocortical axis regulatory factor, T-box 19, and the angry/hostility personality trait. Genes, Brain and Behavior, 6(4), 321–328.
Wasserman, D., Sokolowski, M., Rozanov, V., et al. (2008). The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes, Brain and Behavior, 7(1), 14–19.
Wasserman, D., Sokolowski, M., Wasserman, J., et al. (2009). Neurobiology and the genetics of suicide. In D. Wasserman & C. Wasserman (Eds.) Oxford Textbook of Suicidology – The Five Continents Perspective (pp. 165–182). Oxford, UK: Oxford University Press.
Wasserman, D., Terenius, L., Wasserman, J., et al. (2010). The 2009 Nobel conference on the role of genetics in promoting suicide prevention and the mental health of the population. Molecular Psychiatry, 15(1), 12–17.
Willour, V. L., Seifuddin, F., Mahon, P. B., et al. (2012). A genome-wide association study of attempted suicide. Molecular Psychiatry, 17(4), 433–444.

References

Agid, O., Shapira, B., Zislin, J., et al. (1999). Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Molecular Psychiatry, 4, 163–172.
Aguilera, G., Kiss, A., Liu, Y., & Kamitakahara, A. (2007). Negative regulation of corticotropin-releasing factor expression and limitation of stress response. Stress, 10, 153–161.
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. Journal of Neuroscience Research, 85, 525–535.
Alt, S. R., Turner, J. D., Klok, M. D., et al. (2010). Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology, 35, 544–556.
Andersen, S. L., Tomada, A., Vincow, E. S., et al. (2008). Preliminary evidence for sensitive periods in the effect of childhood sexual abuse on regional brain development. Journal of Neuropsychiatry and Clinical Neuroscience, 20, 292–301.
Aston, C., Jiang, L., & Sokolov, B. P. (2005). Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Molecular Psychiatry, 10, 309–322.
Bannister, A. J., Zegerman, P., Partridge, J. F., et al. (2001). Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature, 410, 120–124.
Barrera, L. O., Li, Z., Smith, A. D., et al. (2008). Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs. Genome Research, 18, 46–59.
Barski, A., Cuddapah, S., Cui, K., et al. (2007). High-resolution profiling of histone methylations in the human genome. Cell, 129, 823–837.
Bensley, L. S., Van Eenwyk, J., Spieker, S. J., & Schoder, J. (1999). Self-reported abuse history and adolescent problem behaviors. I. Antisocial and suicidal behaviors. Journal of Adolescent Health, 24, 163–172.
Bhagwagar, Z. & Cowen, P. J. (2008). ‘It’s not over when it’s over’: persistent neurobiological abnormalities in recovered depressed patients. Psychological Medicine, 38, 307–313.
Botuyan, M. V., Lee, J., Ward, I. M., et al. (2006). Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell, 127, 1361–1373.
Bremner, J. D., Randall, P., Vermetten, E., et al. (1997). Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse – a preliminary report. Biological Psychiatry, 41, 23–32.
Bremner, J. D., Vythilingam, M., Vermetten, E., et al. (2003). MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. American Journal of Psychiatry, 160, 924–932.
Briere, J., & Elliott, D. M. (2003). Prevalence and psychological sequelae of self-reported childhood physical and sexual abuse in a general population sample of men and women. Child Abuse and Neglect, 27, 1205–1222.
Brown, G. W., & Moran, P. (1994). Clinical and psychosocial origins of chronic depressive episodes. I: A community survey. British Journal of Psychiatry, 165, 447–456.
Brunoni, A. R., Lopes, M., & Fregni, F. (2008). A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology, 11, 1169–1180.
Carpenter, L. L., Tyrka, A. R., McDougle, C. J., et al. (2004). Cerebrospinal fluid corticotropin-releasing factor and perceived early life stress in depressed patients and healthy control subjects. Neuropsychopharmacology, 29, 777–784.
Carrion, V. G., Weems, C. F., Eliez, S., et al. (2001). Attenuation of frontal asymmetry in pediatric posttraumatic stress disorder. Biological Psychiatry, 50, 943–951.
Chan, J. P., Unger, T. J., Byrnes, J., & Rios, M. (2006). Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice. Neuroscience, 142, 49–58.
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J. F., & Young, L. T. (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry, 50, 260–265.
Chen, E. S., Ernst, C., & Turecki, G. (2011). The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. International Journal of Neuropsychopharmacology, 14, 427–429.
Chen, W. G., Chang, Q., Lin, Y., et al. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302, 885–889.
Children’s Bureau. (2010). Child maltreatment 2009. In US Department of Health and Human Services, A. O. C., Youth and Families (Ed.). Washington DC: Government Printing Office.
Clements, A., Poux, A. N., Lo, W. S., et al. (2003). Structural basis for histone and phosphohistone binding by the GCN5 histone acetyltransferase. Molecular Cell, 12, 461–473.
Cronholm, B., Asberg, M., Montgomery, S., & Schalling, D. (1977). Suicidal behaviour syndrome with low CSF 5-HIAA. British Medical Journal, 1, 776.
De Bellis, M. D., Keshavan, M. S., Frustaci, K., et al. (2002). Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biological Psychiatry, 51, 544–552.
De Luca, V., Likhodi, O., Kennedy, J. L., & Wong, A. H. (2007). Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism: analysis of suicidality in schizophrenia and bipolar disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144B, 370–374.
De Luca, V., Viggiano, E., Dhoot, R., Kennedy, J. L., & Wong, A. H. (2009). Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis. Journal of Psychiatric Research, 43, 532–537.
Deaton, A. M., Webb, S., Kerr, A. R., et al. (2011). Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Research, 21, 1074–1086.
Dinwiddie, S., Heath, A. C., Dunne, M. P., et al. (2000). Early sexual abuse and lifetime psychopathology: a co-twin-control study. Psychological Medicine, 30, 41–52.
Driessen, M., Herrmann, J., Stahl, K., et al. (2000). Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry, 57, 1115–1122.
Du, L., Bakish, D., Lapierre, Y. D., Ravindran, A. V., & Hrdina, P. D. (2000). Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics, 96, 56–60.
Du, L., Faludi, G., Palkovits, M., Bakish, D., & Hrdina, P. D. (2001). Serotonergic genes and suicidality. Crisis, 22, 54–60.
Duman, R. S., & Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59, 1116–1127.
Duric, V., & McCarson, K. E. (2005). Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience, 133, 999–1006.
Duric, V., & McCarson, K. E. (2006). Effects of analgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. Journal of Pharmacology and Experimental Therapeutics, 319, 1235–1243.
Dwivedi, Y., Rizavi, H. S., Conley, R. R., et al. (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry, 60, 804–815.
Dwivedi, Y., Rizavi, H. S., Zhang, H., et al. (2009). Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biological Psychiatry, 65, 319–328.
Elliott, E., Ezra-Nevo, G., Regev, L., Neufeld-Cohen, A., & Chen, A. (2010). Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nature Neuroscience, 13, 1351–1353.
Ernst, C., Chen, E. S., & Turecki, G. (2009a). Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Molecular Psychiatry, 14, 830–832.
Ernst, C., Deleva, V., Deng, X., et al. (2009b). Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Archives of General Psychiatry, 66, 22–32.
Evans, E., Hawton, K., & Rodham, K. (2005). Suicidal phenomena and abuse in adolescents: a review of epidemiological studies. Child Abuse and Neglect, 29, 45–58.
Fergusson, D. M., Horwood, L. J., & Lynskey, M. T. (1996). Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1365–74.
Fiori, L. M., & Turecki, G. (2008). Implication of the polyamine system in mental disorders. Journal of Psychiatry and Neuroscience, 33, 102–110.
Fischle, W., Tseng, B. S., Dormann, H. L., et al. (2005). Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature, 438, 1116–1122.
Francis, D., Diorio, J., Liu, D., & Meaney, M. J. (1999). Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science, 286, 1155–1158.
Gainer, H., Fields, R. L., & House, S. B. (2001). Vasopressin gene expression: experimental models and strategies. Experimental Neurology, 171, 190–199.
Gilad, G. M., & Gilad, V. H. (2003). Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cellular and Molecular Neurobiology, 23, 637–649.
Gilad, G. M., Gilad, V. H., Eliyayev, Y., & Rabey, J. M. (1998). Developmental regulation of the brain polyamine-stress-response. International Journal of Developmental Neuroscience, 16, 271–8.
Gladstone, G. L., Parker, G. B., Mitchell, P. B., et al. (2004). Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. American Journal of Psychiatry, 161, 1417–1425.
Gorey, K. M., & Leslie, D. R. (1997). The prevalence of child sexual abuse: integrative review adjustment for potential response and measurement biases. Child Abuse and Neglect, 21, 391–398.
Grayson, D. R., Jia, X., Chen, Y., et al. (2005). Reelin promoter hypermethylation in schizophrenia. Proceedings of the National Academy of Sciences USA, 102, 9341–9346.
Gronli, J., Bramham, C., Murison, R., et al. (2006). Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacology, Biochemistry and Behavior, 85, 842–849.
Gross, J. A., Fiori, L. M., Labonté, B., Lopez, J. P., & Turecki, G. (2012). Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. Journal of Psychiatric Research, 47(4), 513–519.
Guidotti, A., Auta, J., Davis, J. M., et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Archives of General Psychiatry, 57, 1061–1069.
Hata, K., Okano, M., Lei, H., & Li, E. (2002). Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development, 129, 1983–1993.
He, L., & Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics, 5, 522–531.
Heckers, S., Stone, D., Walsh, J., et al. (2002). Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Archives of General Psychiatry, 59, 521–529.
Heim, C., & Nemeroff, C. B. (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biological Psychiatry, 49, 1023–1039.
Heim, C., Newport, D. J., Heit, S., et al. (2000). Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA, 284, 592–597.
Heim, C., Mletzko, T., Purselle, D., Musselman, D. L., & Nemeroff, C. B. (2008a). The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biological Psychiatry, 63, 398–405.
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008b). The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology, 33, 693–710.
Heim, C., Young, L. J., Newport, D. J., et al. (2009). Lower CSF oxytocin concentrations in women with a history of childhood abuse. Molecular Psychiatry, 14, 954–958.
Heim, C., Shugart, M., Craighead, W. E., & Nemeroff, C. B. (2010). Neurobiological and psychiatric consequences of child abuse and neglect. Developmental Psychobiology, 52, 671–90.
Ito, S., D’Alessio, A. C., Taranova, O. V., et al. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466, 1129–1133.
Iwamoto, K., Bundo, M., Ueda, J., et al. (2011). Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Research, 21, 688–696.
Jaffee, S. R., Moffitt, T. E., Caspi, A., et al. (2002). Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Archives of General Psychiatry, 59, 215–222.
Kaplan, M. J., & Klinetob, N. A. (2000). Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. Journal of Nervous and Mental Disease, 188, 596–601.
Keller, S., Sarchiapone, M., Zarrilli, F., et al. (2010). Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Archives of General Psychiatry, 67, 258–267.
Kendler, K. S., Bulik, C. M., Silberg, J., et al. (2000). Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. Archives of General Psychiatry, 57, 953–959.
Kendler, K. S., Kuhn, J. W., & Prescott, C. A. (2004). Childhood sexual abuse, stressful life events and risk for major depression in women. Psychological Medicine, 34, 1475–1482.
Kim, Y. K., Lee, H. P., Won, S. D., et al. (2007). Low plasma BDNF is associated with suicidal behavior in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 78–85.
Kirmizis, A., Santos-Rosa, H., Penkett, C. J., et al. (2007). Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature, 449, 928–932.
Klempan, T. A., Sequeira, A., Canetti, L., et al. (2009). Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry, 14, 175–189.
Klose, R. J., & Bird, A. P. (2006). Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences, 31, 89–97.
Kouzarides, T. (2007). Chromatin modifications and their function. Cell, 128, 693–705.
Kriaucionis, S., & Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324, 929–930.
Kundakovic, M., Chen, Y., Costa, E., & Grayson, D. R. (2007). DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Molecular Pharmacology, 71, 644–653.
Labonté, B., Suderman, M., Maussion, G., et al. (2012a). Genome-wide epigenetic regulation by early life trauma. Archives of General Psychiatry, 69, 722–731.
Labonté, B., Yerko, V., Gross, J., et al. (2012b). Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biological Psychiatry, 72, 41–48.
Labonté, B., Suderman, M., Maussion, G., et al. (2013). Genome-wide methylation changes in the suicide brain. American Journal of Psychiatry, 170, 511–520.
Ladd-Acosta, C., Pevsner, J., Sabunciyan, S., et al. (2007). DNA methylation signatures within the human brain. American Journal of Human Genetics, 81, 1304–1315.
Lan, F., Bayliss, P. E., Rinn, J. L., et al. (2007). A histone H3 lysine 27 demethylase regulates animal posterior development. Nature, 449, 689–694.
Laplante, P., Diorio, J. & Meaney, M. J. (2002). Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Research: Developmental Brain Research, 139, 199–203.
Liu, D., Diorio, J., Tannenbaum, B., et al. (1997). Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science, 277, 1659–1662.
Lopez, J. P., Mamdani, F., Labonté, B., et al. (2013). Epigenetic regulation of BDNF expression according to antidepressant response. Molecular Psychiatry, 18, 398–399.
Matrisciano, F., Bonaccorso, S., Ricciardi, A., et al. (2009). Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research, 43, 247–254.
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., et al. (2010). Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature, 466, 253–257.
McCauley, J., Kern, D. E., Kolodner, K., et al. (1997). Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA, 277, 1362–1368.
McCormick, J. A., Lyons, V., Jacobson, M. D., et al. (2000). 5’-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early life events. Molecular Endocrinology, 14, 506–517.
McGowan, P. O., Sasaki, A., Huang, T. C., et al. (2008). Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One, 3, e2085.
McGowan, P. O., Sasaki, A., D’Alessio, A. C., et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12, 342–348.
McGowan, P. O., Suderman, M., Sasaki, A., et al. (2011). Broad epigenetic signature of maternal care in the brain of adult rats. PLoS One, 6, e14739.
Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annual Review of Neuroscience, 24, 1161–1192.
Meaney, M. J., Aitken, D. H. & Sapolsky, R. M. (1987). Thyroid hormones influence the development of hippocampal glucocorticoid receptors in the rat: a mechanism for the effects of postnatal handling on the development of the adrenocortical stress response. Neuroendocrinology, 45, 278–283.
Meaney, M. J., Diorio, J., Francis, D., et al. (2000). Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. Journal of Neuroscience, 20, 3926–3935.
Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell, 151, 1417–1430.
Merali, Z., Du, L., Hrdina, P., et al. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. Journal of Neuroscience, 24, 1478–1485.
Mercier, G., Lennon, A. M., Renouf, B., et al. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. Journal of Molecular Neuroscience, 24, 207–216.
Mill, J., Tang, T., Kaminsky, Z., et al. (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American Journal of Human Genetics, 82, 696–711.
Minguet, E. G., Vera-Sirera, F., Marina, A., Carbonell, J., & Blazquez, M. A. (2008). Evolutionary diversification in polyamine biosynthesis. Molecular Biology and Evolution, 25, 2119–2128.
Mitchell, J. B., Iny, L. J., & Meaney, M. J. (1990). The role of serotonin in the development and environmental regulation of type II corticosteroid receptor binding in rat hippocampus. Brain Research. Developmental Brain Research, 55, 231–235.
Molnar, B. E., Berkman, L. F., & Buka, S. L. (2001). Psychopathology, childhood sexual abuse and other childhood adversities: relative links to subsequent suicidal behaviour in the US. Psychological Medicine, 31, 965–977.
Murgatroyd, C., Patchev, A. V., Wu, Y., et al. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nature Neuroscience, 12, 1559–1566.
Nakatani, N., Hattori, E., Ohnishi, T., et al. (2006). Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Human Molecular Genetics, 15, 1949–1962.
Nelson, C. J., Santos-Rosa, H., & Kouzarides, T. (2006). Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell, 126, 905–916.
Nielsen, S. J., Schneider, R., Bauer, U. M., et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature, 412, 561–565.
Okano, M., XIE, S., & Li, E. (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genetics, 19, 219–220.
Pandey, G. N., Ren, X., Rizavi, H. S., et al. (2008). Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in postmortem brain of teenage suicide victims. International Journal of Neuropsychopharmacology, 11, 1047–1061.
Pariante, C. M., & Lightman, S. L. (2008). The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences, 31, 464–468.
Perroud, N., Paoloni-Giacobino, A., Prada, P., et al. (2011). Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Translational Psychiatry, 1.
Pokholok, D. K., Harbison, C. T., Levine, S., et al. (2005). Genome-wide map of nucleosome acetylation and methylation in yeast. Cell, 122, 517–527.
Polesskaya, O. O., Aston, C., & Sokolov, B. P. (2006). Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. Journal of Neuroscience Research, 83, 362–373.
Poulter, M. O., Du, L., Weaver, I. C., et al. (2008). GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biological Psychiatry, 64, 645–652.
Pray-Grant, M. G., Daniel, J. A., Schieltz, D., Yates, J. R., 3rd & Grant, P. A. (2005). Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature, 433, 434–438.
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics, 90, 397–406.
Radtke, K. M., Ruf, M., Gunter, H. M., et al. (2011). Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Translational Psychiatry, 1, 1–6.
Razzoli, M., Domenici, E., Carboni, L., et al. (2011). A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress. Genes, Brain and Behavior, 10(4), 424–433.
Rhee, H. J., Kim, E. J., & Lee, J. K. (2007). Physiological polyamines: simple primordial stress molecules. Journal of Cellular and Molecular Medicine, 11, 685–703.
Rogoz, Z., Skuza, G., & Legutko, B. (2005). Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. Journal of Physiology and Pharmacology, 56, 661–671.
Rose, C. R., Blum, R., Pichler, B., et al. (2003). Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature, 426, 74–78.
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009). Lasting epigenetic influence of early life adversity on the BDNF gene. Biological Psychiatry, 65, 760–769.
Roth, T. L., Zoladz, P. R., Sweatt, J. D., & Diamond, D. M. (2011). Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. Journal of Psychiatric Research, 45(7), 919–926.
Salcedo-Amaya, A. M., Van Driel, M. A., Alako, B. T., et al. (2009). Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum. Proceedings of the National Academy of Sciences U S A, 106(24), 9655–9660.
Sanders, S. L., Portoso, M., Mata, J., et al. (2004). Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell, 119, 603–614.
Santa Mina, E. E., & Gallop, R. M. (1998). Childhood sexual and physical abuse and adult self-harm and suicidal behaviour: a literature review. Canadian Journal of Psychiatry, 43, 793–800.
Santos-Rosa, H., Schneider, R., Bernstein, B. E., et al. (2003). Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin. Molecular Cell, 12, 1325–1332.
Scher, C. D., Forde, D. R., Mcquaid, J. R., & Stein, M. B. (2004). Prevalence and demographic correlates of childhood maltreatment in an adult community sample. Child Abuse and Neglect, 28, 167–180.
Sen, S., Duman, R., & Sanacora, G. (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry, 64, 527–532.
Sequeira, A., Gwadry, F. G., Ffrench-Mullen, J. M., et al. (2006). Implication of SSAT by gene expression and genetic variation in suicide and major depression. Archives of General Psychiatry, 63, 35–48.
Sequeira, A., Klempan, T., Canetti, L., et al. (2007). Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry, 12, 640–655.
Smythe, J. W., Rowe, W. B., & Meaney, M. J. (1994). Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Brain Research. Developmental Brain Research, 80, 183–189.
Stein, M. B., Koverola, C., Hanna, C., Torchia, M. G., & Mcclarty, B. (1997). Hippocampal volume in women victimized by childhood sexual abuse. Psychological Medicine, 27, 951–959.
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013). Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology, 38, 124–137.
Swigut, T., & Wysocka, J. (2007). H3K27 demethylases, at long last. Cell, 131, 29–32.
Tahiliani, M., Koh, K. P., Shen, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930–935.
Tamura, Y., Kunugi, H., Ohashi, J., & Hohjoh, H. (2007). Epigenetic aberration of the human REELIN gene in psychiatric disorders. Molecular Psychiatry, 12, 519, 593–600.
Tanskanen, A., Hintikka, J., Honkalampi, K., et al. (2004). Impact of multiple traumatic experiences on the persistence of depressive symptoms: a population-based study. Nordic Journal of Psychiatry, 58, 459–464.
Torrey, E. F., Barci, B. M., Webster, M. J., et al. (2005). Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biological Psychiatry, 57, 252–260.
Tsankova, N. M., Berton, O., Renthal, W., et al. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience, 9, 519–525.
Tucker, K. L. (2001). Methylated cytosine and the brain: a new base for neuroscience. Neuron, 30, 649–652.
Turecki, G., Briere, R., Dewar, K., et al. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. American Journal of Psychiatry, 156, 1456–1458.
Turner, J. D., & Muller, C. P. (2005). Structure of the glucocorticoid receptor (NR3C1) gene 5’ untranslated region: identification, and tissue distribution of multiple new human exon 1. Journal of Molecular Endocrinology, 35, 283–292.
Turner, J. D., Pelascini, L. P., Macedo, J. A., & Muller, C. P. (2008). Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acids Research, 36, 7207–7218.
Turner, J. D., Alt, S. R., Cao, L., et al. (2010). Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochemical Pharmacology, 80, 1860–1868.
Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012). Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One, 7, e30148.
Uddin, M., Aiello, A. E., Wildman, D. E., et al. (2010). Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proceedings of the National Academy of Sciences U S A, 107, 9470–9475.
Veldic, M., Caruncho, H. J., Liu, W. S., et al. (2004). DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proceedings of the National Academy of Sciences U S A, 101, 348–353.
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000). Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry, 57, 237–245.
Wang, Z., Zang, C., Rosenfeld, J. A., et al. (2008). Combinatorial patterns of histone acetylations and methylations in the human genome. Nature Genetics, 40, 897–903.
Weaver, I. C., Cervoni, N., Champagne, F. A., et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7, 847–854.
Wysocka, J., Swigut, T., Milne, T. A., et al. (2005). WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell, 121, 859–872.
Wysocka, J., Swigut, T., Xiao, H., et al. (2006). A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature, 442, 86–90.
Xiao, T., Shibata, Y., Rao, B., et al. (2007). The RNA polymerase II kinase Ctk1 regulates positioning of a 5’ histone methylation boundary along genes. Molecular and Cellular Biology, 27, 721–731.
Xu, H., Chen, Z., He, J., et al. (2006). Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus, 16, 551–559.
Zhang, T. Y., Hellstrom, I. C., Bagot, R. C., et al. (2010). Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. Journal of Neuroscience, 30, 13 130–13 137.
Zhou, Z., Hong, E. J., Cohen, S., et al. (2006). Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52, 255–269.
Zlotnick, C., Mattia, J., & Zimmerman, M. (2001). Clinical features of survivors of sexual abuse with major depression. Child Abuse and Neglect, 25, 357–367.

References

Aghajanian, G. K., Sprouse, J. S., & Rasmussen, K. (1987). Physiology of the midbrain 5-HT system. In H. Y. Meltzer (Ed.) Psychopharmacology: the Third Generation of Progress (pp 141–148). New York: Raven.
Ahearn, E. P., Jamison, K. R., Steffens, D. C., et al. (2001). MRI correlates of suicide attempt history in unipolar depression. Biological Psychiatry, 50(4), 266–270.
Asberg, M., Träskman, L., & Thorén, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor?Archives of General Psychiatry, 33(10), 1193–1197.
Audenaert, K., Van Laere, K., Dumont, F., et al. (2001). Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. European Journal of Nuclear Medicine, 28(2), 175–182.
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2008). Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. Journal of Psychiatric Research, 42(6), 433–442.
Bortolato, M., Pivac, N., Seler, D. M., et al. (2013). The role of serotonergic system at the interface of aggression and suicide. Neuroscience, 236, 160–185.
Bridge, J. A., McBee-Strayer, S. M., Cannon, E. A., et al. (2012). Impaired decision-making in adolescent suicide attempters. Journal of the American Academy of Child and Adolescent Psychiatry, 51(4), 394–403.
Chamberlain, S. R., Odlaug, B. L., Schreiber, L. R., & Grant, J. E. (2013). Clinical and neurocognitive markers of suicidality in young adults. Journal of Psychiatric Research, 47(5), 586–591.
Chantiluke, K., Halari, R., Simic, M., et al. (2012). Fronto-striato-cerebellar dysregulation in adolescents with depression during motivated attention. Biological Psychiatry, 71(1), 59–67.
Clark, L., Dombrovski, A. Y., Siegle, G. J., et al. (2011). Impairment in risk-sensitive decision-making in older suicide attempters with depression. Psychology and Aging, 26(2), 321–330.
Crunelle, C. L., Veltman, D. J., Booij, J., Emmerik-van Oortmerssen, K., & van den Brink, W. (2012). Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain Behavior, 2(4), 499–523.
Cyprien, F., Courtet, P., Malafosse, A., et al. (2011). Suicidal behavior is associated with reduced corpus callosum area. Biological Psychiatry, 70(4), 320–326.
Desmyter, S., van Heeringen, C., & Audenaert, K. (2011). Structural and functional neuroimaging studies of the suicidal brain. Progress in Neuropsychopharmacology and Biological Psychiatry, 35(4), 796–808.
Dombrovski, A. Y., Siegle, G. J., Szanto, K., et al. (2012). The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychological Medicine, 42(6), 1203–1215.
Fawcett, J. (2012). Diagnosis, traits, states, and comorbidity in suicide. In Y. Dwivedi (Ed.) The Neurobiological Basis of Suicide (Chapter 1. Frontiers in Neuroscience). Boca Raton, FL: CRC Press.
Fritz, J., & Dreisbach, G. (2013). Conflicts as aversive signals: Conflict priming increases negative judgments for neutral stimuli. Cognitive, Affective and Behavioral Neuroscience, 13(2), 311–317.
Gasquoine, P. G. (2013). Localization of function in anterior cingulate cortex: From psychosurgery to functional neuroimaging. Neuroscience and Biobehavioral Reviews, 37(3), 340–348.
Guillaume, S., Perroud, N., Jollant, F., et al. (2013). HPA axis genes may modulate the effect of childhood adversities on decision-making in suicide attempters. Journal of Psychiatric Research, 47(2), 259–265.
Jiao, Q., Ding, J., Lu, G., et al. (2011). Increased activity imbalance in fronto-subcortical circuits in adolescents with major depression. PLoS One, 6(9), e25159.
Jollant, F., Lawrence, N. S., Olie, E., et al. (2010). Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage, 51(3), 1275–1281.
Kanske, P., & Kotz, S. A. (2012). Effortful control, depression, and anxiety correlate with the influence of emotion on executive attentional control. Biological Psychology, 91(1), 88–95.
Kasper, S., Schindler, S., & Neumeister, A. (1996). Risk of suicide in depression and its implication for psychopharmacological treatment. International Clinical Psychopharmacology, 11(2), 71–79
Keilp, J. G., Gorlyn, M., Russell, M., et al. (2012). Neuropsychological function and suicidal behavior: attention control, memory and executive dysfunction in suicide attempt. Psychological Medicine, 10, 1–13.
Kempton, M. J., Salvador, Z., Munafò, M. R., et al. (2011). Structural neuroimaging studies in major depressive disorder: Meta-analysis and comparison with bipolar disorder. Archives of General Psychiatry, 68(7), 675–690.
Lindström, M. B., Ryding, E., Bosson, P., et al. (2004). Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. European Neuropsychopharmacology, 14(4), 295–300.
Luo, S., Ainslie, G., Giragosian, L., & Monterosso, J. R. (2009). Behavioral and neural evidence of incentive bias for immediate rewards relative to preference-matched delayed rewards. Journal of Neuroscience, 29(47), 14 820–14 827.
Mahon, K., Burdick, K. E., Wu, J., Ardekani, B. A., & Szeszko, P. R. (2012). Relationship between suicidality and impulsivity in bipolar I disorder: a diffusion tensor imaging study. Bipolar Disorder, 14(1), 80–89.
Mann, J. J., Huang, Y. Y., Underwood, M. D., et al. (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry, 57(8), 729–738.
Marchand, W. R., Lee, J. N., Healy, L., et al. (2009). An fMRI motor activation paradigm demonstrates abnormalities of putamen activation in females with panic disorder. Journal of Affective Disorders, 116(1–2), 121–125.
Marchand, W. R., Lee, J. N., Garn, C., et al. (2011). Striatal and cortical midline activation and connectivity associated with suicidal ideation and depression in bipolar II disorder. Journal of Affective Disorders, 133(3), 638–645.
Marchand, W. R., Lee, J. N., Johnson, S., et al. (2012). Striatal and cortical midline circuits in major depression: implications for suicide and symptom expression. Progress in Neuropsychopharmacology and Biological Psychiatry, 36(2), 290–299.
Matthews, S., Spadoni, A., Knox, K., Strigo, I., & Simmons, A. (2012). Combat-exposed war veterans at risk for suicide show hyperactivation of prefrontal cortex and anterior cingulate during error processing. Psychosomatic Medicine, 74(5), 471–475.
Meyer, J. H. (2012). Neuroimaging high-risk states for suicide. In Y. Diwivedi (Ed.) The Neurobiological Basis for Suicide (pp. 159–194). Boca Raton, FL: CRC Press.
Meyer, J. H., Kapur, S., Houle, S., et al. (1999). Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. American Journal of Psychiatry, 156(7), 1029–1034.
Murrough, J. W., & Neumeister, A. (2011). The serotonin 1B receptor: a new target for depression therapeutics?Biological Psychiatry, 69(8), 714–715.
Nery-Fernandes, F., Rocha, M. V., Jackowski, A., et al. (2012). Reduced posterior corpus callosum area in suicidal and non-suicidal patients with bipolar disorder. Journal of Affective Disorders, 142(1–3), 150–155.
Neumeister, A. (2013). The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depression and Anxiety, 30(2), 93–96.
Neumeister, A., Hu, X. Z., Luckenbaugh, D. A., et al. (2006). Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Archives of General Psychiatry, 63(9), 978–986.
Nikolaus, S., Hautzel, H., Heinzel, A., Müller, HW. (2012). Key players in major and bipolar depression: a retrospective analysis of in vivo imaging studies. Behavioural Brain Research, 232(2), 358–390.
Nugent, A. C., Neumeister, A., Goldman, D., et al. (2008). Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion. Neuroimage, 43(4), 764–774.
Nye, J. A., Purselle, D., Plisson, C., et al. (2013). Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-Zient PET imaging. Depression and Anxiety, 30(10), 902–907.
Pan, L., Segreti, A., Almeida, J., et al. (2013a). Preserved hippocampal function during learning in the context of risk in adolescent suicide attempt. Psychiatry Research, 211(2), 112–118.
Pan, L. A., Hassel, S., Segreti, A. M., et al. (2013b). Differential patterns of activity and functional connectivity in emotion processing neural circuitry to angry and happy faces in adolescents with and without suicide attempt. Psychological Medicine, 43(10), 2129–2142.
Parsey, R. V., Hastings, R. S., Oquendo, M. A., et al. (2006). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry, 163, 52–58.
Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., et al. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. American Journal of Psychiatry, 166(6), 702–710.
Raust, A., Slama, F., Mathieu, F., et al. (2007). Prefrontal cortex dysfunction in patients with suicidal behavior. Psychological Medicine, 37(3), 411–419.
Reisch, T., Seifritz, E., Esposito, F., et al. (2010). An fMRI study on mental pain and suicidal behavior. Journal of Affective Disorder, 126(1–2), 321–325.
Rudd, M. D. (2000). The suicidal mode: a cognitive-behavioral model of suicidality. Suicide and Life-Threatening Behavior, 30(1), 18–33.
Sanacora, G., Treccani, G., & Popoli, M. (2012). Toward a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology, 62(1), 63–77.
Savitz, J. B., & Drevets, W. C. (2012). Neuroreceptor imaging in depression. Neurobiology of Disease. Jun 9 [Epub ahead of print].
Soloff, P., Nutche, J., Goradia, D., & Diwadkar, V. (2008). Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Research, 164(3), 223–236.
Soloff, P. H., Pruitt, P., Sharma, M., et al. (2012). Structural brain abnormalities and suicidal behavior in borderline personality disorder. Journal of Psychiatric Research, 46(4), 516–525.
Spoletini, I., Piras, F., Fagioli, S., et al. (2011). Suicidal attempts and increased right amygdala volume in schizophrenia. Schizophrenia Research, 125(1), 30–40.
Stockmeier, C. A., Shapiro, L. A., Dilley, G. E., et al. (1998). Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. Journal of Neuroscience, 18(18), 7394–7401.
Takahashi, T., Yücel, M., Lorenzetti, V., et al. (2009). Midline brain structures in patients with current and remitted major depression. Progress in Neuropsychopharmacology and Biological Psychiatry, 33(6), 1058–1063.
Underwood, M. D., Kassir, S. A., Bakalian, M. J., et al. (2012). Neuron density and serotonin receptor binding in prefrontal cortex in suicide. International Journal of Neuropsychopharmacology, 15(4), 435–447.
Vang, F. J., Ryding, E., Träskman-Bendz, L., van Westen, D., & Lindström, M. B. (2010). Size of basal ganglia in suicide attempters, and its association with temperament and serotonin transporter density. Psychiatry Research, 183(2), 177–179.
Wagner, G., Koch, K., Schachtzabel, C., et al. (2011). Structural brain alterations in patients with major depressive disorder and high-risk for suicide: evidence for a distinct neurobiological entity?Neuroimage, 54(2), 1607–1614.
Wagner, G., Schultz, C. C., Koch, K., et al. (2012). Prefrontal cortical thickness in depressed patients with high-risk for suicidal behavior. Journal of Psychiatric Research, 46(11), 1449–1455.
Wozniak, J., Gonenc, A., Biederman, J., et al. (2012). A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation. Israel Journal of Psychiatry and Related Sciences, 49(1), 62–69.
Zhu, X., Peng, S., Zhang, S., & Zhang, X. (2011). Stress-induced depressive behaviors are correlated with Par-4 and DRD2 expression in rat striatum. Behavioural Brain Research, 223(2), 329–335.

References

Arango, V., & Mann, J. J. (1992). Relevance of serotonergic postmortem studies to suicidal behavior. International Review of Psychiatry, 4, 131–140.
Arango, V., Ernsberger, P., Marzuk, P. M., et al. (1990). Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Archives of General Psychiatry, 47(11), 1038–1047.
Arango, V., Underwood, M. D., Gubbi, A. V., & Mann, J. J. (1995). Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research, 688(1–2), 121–133.
Arango, V., Underwood, M. D., Boldrini, M., et al. (2001). Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology, 25(6), 892–903.
Arango, V., Underwood, M. D., & Mann, J. J. (2002). Serotonin brain circuits involved in major depression and suicide. Progress in Brain Research, 136, 443–453.
Åsberg, M., Träskman, L., & Thorén, P. (1976). 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor?Archives of General Psychiatry, 33(10), 1193–1197.
Bach, H., Huang, Y. Y., Underwood, M. D., et al. (2013). Elevated serotonin and 5-HIAA in the brainstem and lower serotonin turnover in the prefrontal cortex of suicides, Synapse. Jun 29. doi: 10.1002/syn.21695. [Epub ahead of print].
Bach-Mizrachi, H., Underwood, M. D., Kassir, S. A., et al. (2006). Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology, 31(4), 814–824.
Beaulieu, J. M., Zhang, X., Rodriguiz, R. M., et al. (2008). Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America, 105(4), 1333–1338.
Bligh-Glover, W., Kolli, T. N., Shapiro-Kulnane, L., et al. (2000). The serotonin transporter in the midbrain of suicide victims with major depression. Biological Psychiatry, 47, 1015–1024.
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2005). More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Research, 1041(1), 19–28.
Boldrini, M., Underwood, M. D., Mann, J. J., & Arango, V. (2008). Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. Journal of Psychiatric Research, 42(6), 433–442.
Bonkale, W. L., Murdock, S., Janosky, J. E., & Austin, M. C. (2004). Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims. Journal of Neurochemistry, 88(4), 958–964.
Donner, N. C., Johnson, P. L., Fitz, S. D., et al. (2012). Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depression and Anxiety, 29(4), 307–319.
Dwivedi, Y. & Pandey, G. N. (2011). Elucidating biological risk factors in suicide: role of protein kinase A. Progress in Neuropsychopharmacology and Biological Psychiatry, 35(4), 831–841.
Gardner, K. L., Hale, M. W., Oldfield, S., et al. (2009). Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience, 163(4), 991–1001.
Haghighi, F., Bach-Mizrachi, H., Huang, Y. Y., et al. (2008). Genetic architecture of the human tryptophan hydroxylase 2 gene: existence of neural isoforms and relevance for major depression. Molecular Psychiatry, 13(8), 813–820.
Hrdina, P. D., Demeter, E., Vu, T. B., Sótónyi, P., & Palkovits, M. (1993). 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5- HT2 sites in cortex and amygdala. Brain Research, 614, 37–44.
Mann, J. J., Stanley, M., McBride, P. A., & McEwen, B. S. (1986). Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry, 43(10), 954–959.
Mann, J. J., Huang, Y. Y., Underwood, M. D., et al. (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry, 57(8), 729–738.
Mann, J. J., Brent, D. A., & Arango, V. (2001). The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology, 24(5), 467–477.
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., et al. (2002). Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. American Journal of Psychiatry, 159(3), 419–429.
Parsey, R. V., Hastings, R. S., Oquendo, M. A., et al. (2006). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry, 163(1), 52–58.
Stanley, M., & Mann, J. J. (1983). Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet, 1(8318), 214–216.
Stockmeier, C. A., Dilley, G. E., Shapiro, L. A., et al. (1997). Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology, 16(2), 162–173.
Stockmeier, C. A., Shapiro, L. A., Dilley, G. E., et al. (1998). Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. Journal of Neuroscience, 18(18), 7394–7401.
Stockmeier, C. A., Howley, E., Shi, X., et al. (2009). Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. Journal of Psychiatric Research, 43(10), 887–894.
Turecki, G., Briere, R., Dewar, K., et al. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. American Journal of Psychiatry, 156(9), 1456–1458.
Underwood, M. D., Khaibulina, A. A., Ellis, S. P., et al. (1999). Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biological Psychiatry, 46(4), 473–483.
Underwood, M. D., Kassir, S. A., Bakalian, M. J., Galfalvy, H., Mann, J. J., & Arango, V. (2012). Neuron density and serotonin receptor binding in prefrontal cortex in suicide. International Journal of Neuropsychopharmacology, 15(4), 435–447.

References

Banasr, M., Dwyer, J. M., & Duman, R. S. (2011). Cell atrophy and loss in depression: reversal by antidepressant treatment. Current Opinion in Cell Biology, 23, 730–737.
Bekar, L. K., He, W., & Nedergaard, M. (2008). Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. Cerebral Cortex, 18, 2789–2795.
Berman, R. M., Narasimhan, M., Miller, H. L., et al. (1999). Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?Archives of General Psychiatry, 56, 395–403.
Blier, P., Ward, H. E., Tremblay, P., et al. (2010). Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. The American Journal of Psychiatry, 167, 281–288.
Booij, L., Van der Does, A. J., & Riedel, W. J. (2003). Monoamine depletion in psychiatric and healthy populations: review. Molecular Psychiatry, 8, 951–973.
Chandley, M., & Ordway, G. (2012). Noradrenergic function in suicide. In Y. Dwivedi (Ed) Neurobiology of Suicide (pp. 29–63). Boca Raton, FL: CRC Press.
Chandley, M. J., Szebeni, K., Szebeni, A., et al. (2013). Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. Journal of Psychiatry & Neuroscience, 38, 276–284.
Dawe, G. S., Huff, K. D., Vandergriff, J. L., et al. (2001). Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biological Psychiatry, 50, 510–520.
De Paermentier, F., Mauger, J. M., Lowther, S., et al. (1997). Brain alpha-adrenoceptors in depressed suicides. Brain Research, 757, 60–68.
Duncan, J., Johnson, S., & Ou, X. M. (2012). Monoamine oxidases in major depressive disorder and alcoholism. Drug Discoveries & Therapeutics, 6, 112–122.
Frazer, A. (2000). Norepinephrine involvement in antidepressant action. The Journal of Clinical Psychiatry, 61, 25–30.
Frazer, A., Hess, M. E., Mendels, J., et al. (1978). Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat. The Journal of Pharmacology and Experimental Therapeutics, 206, 311–319.
Galfalvy, H., Currier, D., Oquendo, M. A., et al. (2009). Lower CSF MHPG predicts short-term risk for suicide attempt. International Journal of Neuropsychopharmacology, 12, 1327–1335.
Gos, T., Krell, D., Bielau, H., et al. (2008). Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. European Archives of Psychiatry and Clinical Neuroscience, 258, 513–520.
Grant, M. M., & Weiss, J. M. (2001). Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biological Psychiatry, 49, 117–129.
Karolewicz, B., Stockmeier, C. A., & Ordway, G. A. (2005). Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. Neuropsychopharmacology, 30, 1557–1567.
Kasper, S., Montgomery, S. A., Möller, H. J., et al. (2010). Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder. The World Journal of Biological Psychiatry, 11, 36–44.
Machado-Vieira, R., Ibrahim, L., Henter, I. D., et al. (2012). Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacology, Biochemistry, and Behavior, 100, 678–687.
Mandela, P., & Ordway, G. A. (2006). The norepinephrine transporter and its regulation. Journal of Neurochemistry, 97, 310–333.
Meyer, J. H. (2012). Neuroimaging high-risk states for suicide. In Y. Dwivedi (Ed) The Neurobiological Basis of Suicide (pp. 159–194). Boca Raton, FL: CRC Press.
Neumeister, A., Drevets, W. C., Belfer, I., et al. (2006). Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology, 31, 1750–1756.
Ordway, G. A. (1997). Pathophysiology of the locus coeruleus in suicide. Annals of the New York Academy of Sciences, 836, 233–252.
Ordway, G. A. (2007). Neuropathology of central norepinephrine in psychiatric disorders: postmortem research. In G. A. Ordway, M. Schwartz, & A. Frazer (Eds.) Brain Norepinephrine (pp. 341–362). Cambridge, UK: Cambridge University Press.
Rovin, M. L., Boss-Williams, K. A., Alisch, R. S., et al. (2012). Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Neuropeptides, 46, 81–91.
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., et al. (2002). Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. The American Journal of Geriatric Psychiatry, 10, 541–550.
Sequeira, A., Mamdani, F., Lalovic, A., et al. (2004). Alpha 2A adrenergic receptor gene and suicide. Psychiatry Research, 125, 87–93.
Sharma, A., Busnello, J. V., Ribeiro, L., et al. (2007). Suicidality scores during double-blind fluoxetine and desipramine treatment in Mexican Americans. Journal of Clinical Psychopharmacology, 27, 99–101.
Stone, E. A., Lin, Y., Sarfraz, Y., et al. (2009). Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist. Brain Research, 1291, 21–31.
Taneja, M., Salim, S., Saha, K., et al. (2011). Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience. Behavioural Brain Research, 221, 25–33.
West, C. H., Ritchie, J. C., Boss-Williams, K. A., et al. (2009). Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. International Journal of Neuropsychopharmacology, 12, 627–641.
Zamalloa, T., Bailey, C. P., & Pineda, J. (2009). Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents. British Journal of Pharmacology, 156, 649–661.
Zhao, Z., Baros, A. M., Zhang, H. T., et al. (2008). Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology, 33, 3190–3200.
Zhu, M. Y., Klimek, V., Dilley, G. E., et al. (1999). Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biological Psychiatry, 46, 1275–1286.

References

Arato, M., Banki, C. M., Nemeroff, C. B., et al. (1986). Hypothalamic-pituitary-adrenal axis and suicide. Annals of the New York Academy of Sciences, 487, 263–270.
Austin, M. C., Janosky, J. E., & Murphy, H. A. (2003). Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Molecular Psychiatry, 8, 324–332.
Bissette, G., Klimek, V., Pan, J., et al. (2003). Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology, 28, 1328–1335.
Coryell, W., & Schlesser, M. (2001). The dexamethasone suppression test and suicide prediction. American Journal of Psychiatry, 158, 748–753.
Gold, P. W., Drevets, W. C., & Charney, D. S. (2002). New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biological Psychiatry, 52, 381–385.
Herringa, R. J., Roseboom, P. H., & Kalin, N. H. (2006). Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects. Neuropsychopharmacology, 31, 1822–1831.
Heuser, I., Yassouridis, A., & Holsboer, F. (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research, 28, 341–356.
Hiroi, N., Wong, M. L., Licinio, J., et al. (2001). Expression of corticotropin-releasing hormone receptors type I and type II mRNA in suicide victims and controls. Molecular Psychiatry, 6, 540–546.
Hucks, D., Lowther, S., Crompton, M. R., et al. (1997). Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berlin), 134, 174–178.
Klok, M. D., Alt, S. R., Irurzun Lafitte, A. J., et al. (2011). Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. Journal of Psychiatric Research, 45, 871–878.
Lester, D. (1992). The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry, 25, 265–270.
Lombardo, K. A., Herringa, R. J., Balachandran, J. S., et al. (2001). Effects of acute and repeated restraint stress on corticotropin-releasing hormone binding protein mRNA in rat amygdala and dorsal hippocampus. Neuroscience Letters, 302, 81–84.
Lopez, J. F., Chalmers, D. T., Little, K. Y., et al. (1998). A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry, 43, 547–573.
McGowan, P. O., Sasaki, A., D’Alessio, A. C., et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12, 342–348.
Merali, Z., Du, L., Hrdina, P., et al. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. Journal of Neuroscience, 24, 1478–1485.
Merali, Z., Kent, P., Du, L., et al. (2006). Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biological Psychiatry, 59, 594–602.
Nemeroff, C. B., Widerlov, E., Bissette, G., et al. (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science, 226, 1342–1344.
Nemeroff, C. B., Owens, M. J., Bissette, G., et al. (1988). Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry, 45, 577–579.
Papiol, S., Arias, B., Gasto, C., et al. (2007). Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. Journal of Affective Disorders, 104, 83–90.
Perlman, W. R., Webster, M. J., Kleinman, J. E., et al. (2004). Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biological Psychiatry, 56, 844–852.
Pfennig, A., Kunzel, H. E., Kern, N., et al. (2005). Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biological Psychiatry, 57, 336–342.
Raadsheer, F. C., Hoogendijk, W. J., Stam, F. C., et al. (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology, 60, 436–444.
Raadsheer, F. C., Van Heerikhuize, J. J., Lucassen, P. J., et al. (1995). Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. American Journal of Psychiatry, 152, 1372–1376.
Steckler, T., & Holsboer, F. (1999). Corticotropin-releasing hormone receptor subtypes and emotion. Biological Psychiatry, 46, 1480–1508.
Vale, W., Spiess, J., Rivier, C., et al. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213, 1394–1397.
Wasserman, D., Wasserman, J., & Sokolowski, M. (2010). Genetics of HPA-axis, depression and suicidality. European Psychiatry, 25, 278–280.
Webster, M. J., Knable, M. B., O’grady, J., et al. (2002). Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry, 7, 985–994, 924.
Yerevanian, B. I., Olafsdottir, H., Milanese, E., et al. (1983). Normalization of the dexamethasone suppression test at discharge from hospital: its prognostic value. Journal of Affective Disorders, 5, 191–197.

References

Brandon, E. P., Logue, S. F., Adams, M. R., et al. (1998). Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. Journal of Neuroscience, 18, 3639–3649.
Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., et al. (2003). Insights into G protein structure, function, and regulation. Endocrinology Reviews, 24, 765–781.
Coull, M. A., Lowther, S., Katona, C. L., et. al. (2000). Altered brain protein kinase C in depression: a post-mortem study. European Journal of Neuropsychopharmacology, 10, 283–288.
Cowburn, R. F., Marcusson, J. O., Eriksson, A., et al. (1994). Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Research, 633, 297–304.
Dawood, T., Anderson. J., Barton, D., et al. (2007). Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Molecular Psychiatry, 12, 981–983.
Deveci, A., Aydemir, O., Taskin, O., et al. (2007). Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology, 56, 93–97.
Donati, R. J., Dwivedi, Y., Roberts, R. C., et al. (2008). Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase. Journal of Neuroscience, 28, 3042–3050.
Dowlatshahi, D., MacQueen, G. M., Wang, J. F., et al. (1998). Increased temporal cortex CREB concentrations and antidepression treatment in major depression. Lancet, 352, 1754–1755.
Dowlatshahi, D., MacQueen, G. M., Wang, et al. (1999). G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry, 73, 1121–1126.
Duman, C. H., Schlesinger, L., Kodama, M., et al. (2007). A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry, 61, 661–670.
Duric, V., Banasr, M., Licznerski, P., et al. (2010). A negative regulator of MAP kinase causes depressive behavior. Nature Medicine, 16, 1328–1332.
Dwivedi, Y., Rizavi, H. S., Roberts, R. C., et al. (2001). Reduced activation and expression of ERK1/2 MAP kinase in the postmortem brain of depressed suicide subjects. Journal of Neurochemistry, 77, 916–928.
Dwivedi, Y., Conley, R. R., Roberts, R. C., et al. (2002a). [3H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. American Journal of Psychiatry, 159, 66–73.
Dwivedi, Y., Rizavi, H. S., Conley, R. R., et al. (2002b). mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology, 27, 499–517.
Dwivedi, Y., Rizavi, H. S., Conley, R. R., et al. (2003a). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry, 60, 804–815.
Dwivedi, Y., Rao, J. S., Rizavi, H. S., et al. (2003b). Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element-binding protein in postmortem brain of suicide subjects. Archives of General Psychiatry, 60, 273–282.
Dwivedi, Y., Rizavi, H. S., Shukla, P. K., et al. (2004). Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biological Psychiatry, 55, 234–243.
Dwivedi, Y., Rizavi, H. S., Conley, R. R., et al. (2006). ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Molecular Psychiatry, 11, 86–98.
Dwivedi, Y., Rizavi, H. S., Zhang, H., et al. (2009a). Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). Int J Neuropsychopharmacology, 12, 1337–1354.
Dwivedi, Y., Rizavi, H., Zhang, H., et al. (2009b). Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biological Psychiatry, 65, 319–328.
Einat, H., Yuan, P., Gould, T. D., et al. (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience, 23, 7311–7316.
Engel, S. R., Creson, T. K., Hao, Y., et al. (2009). The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Molecular Psychiatry, 14, 448–461.
Ernst, C., Deleva, V., Deng, X., et al. (2009). Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Archives of General Psychiatry, 66, 22–32.
Friedman, W. (2000). Neurotrophins induce death of hippocampal neurons via the p75 receptor. Journal of Neurosciemce, 28, 6340–6346.
Fukami, K., Inanobe, S., Kanemaru, K., et al. (2010). Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Progress in Lipid Research, 49, 429–437.
Gurguis, G. N., Turkka, J., Laruelle, M., et al. (1999). Coupling efficiency of brain beta-adrenergic receptors to Gs protein in suicide, alcoholism and control subjects. Psychopharmacology (Berlin), 145, 31–38.
Hamm, H. E. (1998). The many faces of G protein signaling. Journal of Biological Chemistry, 273, 669–672.
Hashimoto, R., Numakawa, T., Ohnishi, T., et al. (2006). Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Human Molecular Genetics, 15, 3024–3033.
Hildebrandt, J. D. (1997). Role of subunit diversity in signaling by heterotrimeric G proteins. Biochemical Pharmacology, 54, 325–339.
Karege, F., Schwald, M., & Cisse, M. (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters, 328, 261–264.
Karege, F., Vaudan, G., Schwald, M., et al. (2005). Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Research. Molecular Brain Research, 136, 29–37.
Lee, B. H., & Kim, Y. K. (2009). Reduced platelet BDNF level in patients with depression. Progress in Neuropsychopharmacology and Biological Psychiatry, 33, 849–853.
Lee, B. H., Kim, H., Park, S. H., et al. (2007). Decreased plasma BDNF level in depressive patients. Journal of Affective Disorders, 101, 239–244.
Marinissen, M. J., & Gutkind, J. S. (2001). G-protein-coupled receptors and signaling networks: Emerging paradigms. Trends in Pharmacological Sciences, 22, 368–376.
McNamara, R. K., Hyde, T. M., Kleinman, J. E., & Lenox, R. H. (1999). Expression of the myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP) in the prefrontal cortex and hippocampus of suicide victims. Journal of Clinical Psychiatry, 60(Suppl 2), 21–26.
Meldolesi, J., Sciorati, C., & Clementi, E. (2000). The p75 receptor: first insights into the transduction mechanisms leading to either cell death or survival. Trends in Pharmacological Sciences, 21, 242–243.
Miller, F. D., & Kaplan, D. R. (2001). Neurotrophin signaling pathways regulating neuronal apoptosis. Cellular and Molecular Life Sciences, 58, 1045–1053.
Neves, S. R., Ram, P. T., & Iyengar, R. (2002). G protein pathways. Science, 296, 1636–1639.
Odagaki, Y., Garcia-Sevilla, J. A., Huguelet. P., et al. (2001). Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Research, 898, 224–231.
Pacheco, M. A., Stockmeier, C., Meltzer, H. Y., et al. (1996). Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Research, 723, 37–45.
Pandey, G. N., Dwivedi, Y., Pandey, S. C., et al. (1999). Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C β1 protein in the PFC of teenage suicide subjects. American Journal of Psychiatry, 156, 1895–1901.
Pandey, G. N., Dwivedi, Y., Ren, X., et al. (2003). Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. Journal of Psychiatric Research, 37, 421–432.
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., et al. (2004). Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Archives of General Psychiatry, 61, 685–693.
Pandey, G. N., Dwivedi, Y., Ren, X., et al. (2006). Cyclic AMP response element-binding protein in postmortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. International Journal of Neuropsychopharmacology, 18, 1–9.
Pandey, G. N., Ren, X., Rizavi, H. S., et al. (2008). Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. International Journal of Neuropsychopharmacology, 11, 1047–1061.
Qi, X., Lin, W., Li, J., et al. (2006). The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behavioural Brain Research, 175, 233–240.
Qi, X., Lin, W., Li, J., et al. (2008). Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiology of Diseases, 31, 278–285.
Roux, P. P., Colicos, M. A., Barker, P. A., et al. (1999). p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. Journal of Neuroscience, 19, 6887–6896.
Shelton, R. C., Sanders-Bush, E., Manier, D. H., et al. (2009a). Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience, 158, 1406–1415.
Shelton, R. C., Hal, Manier D., & Lewis, D. A. (2009b). Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls. International Journal of Neuropsychopharmacology, 12, 1223–1232.
Thiele, T. E., Willis, B., Stadler, J., et al. (2000). High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. Journal of Neuroscience, 20, RC75.
Wettschureck, N., & Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiological Reviews, 85, 1159–1204.
Young, L. T., Bezchlibnyk, Y. B., Chen, B., et al. (2004). Amygdala cyclic adenosine monophosphate response element-binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biological Psychiatry, 55, 570–577.